期刊文献+

利福昔明的合成研究 被引量:1

Study on the Synthesis of Rifaximin
下载PDF
导出
摘要 以利福霉素S、液溴、2-氨基-4-甲基吡啶、抗坏血酸(VC)为主要原料,经过溴化、环合、还原三个步骤制备了利福昔明。结果表明,最优工艺条件为:溴化反应采用乙醇和水溶剂体系,利福霉素S与溴的摩尔比为1∶1.2;环合反应中3-Br-利福霉素S与2-氨基-4-甲基吡啶的摩尔比为1∶1.6,反应温度为63℃。在该优化条件下,产品总收率达85.1%。 In this paper, rifaximin was prepared with rifamycin S, bromine, 2-amino-4-methylpyridine and vitamin C as the main raw material, via three steps of bromination, cyclization and reduction. The result showed that the optimum reaction conditions were determined as follows: In reduction, the solvent was ethanol/water and the molar ratio of rifamycin S to bromine of 1 ∶1.2. In cyclization, the molar ratio of rifamycin S to 2-amino-4-methyl-pyridine of 1∶1.6 and the reaction temperature is 60 ℃. Under the optimum condition, the yield of the product reached 85.1%.
出处 《浙江化工》 CAS 2016年第8期21-24,54,共5页 Zhejiang Chemical Industry
关键词 利福昔明 合成 工艺优化 rifaximin synthesis process optimization
  • 相关文献

参考文献10

  • 1Feret B, Barner B. Rifaximin: a nonabsorbable, broad- spectrum antibiotic for reduction in the risk for recurrenee of overt hepatic encephalopathy[J]. Formulary, 2010, 45 (7): 210-216. 被引量:1
  • 2Baker D E. Rifaximin: a nonabsorbed oral antibiotic [J]. Rev. Gastroenterol. Disord., 2005, 5 (1):19-30. 被引量:1
  • 3Layer P, resen V. Review article: rifaximin: a minimally absorbed oral antibacterial, for the treatment of travellers' diarrhoea[J]. Aliment. Pharmacol. Ther., 2010, 31 (11): 1155-1164. 被引量:1
  • 4Pimentel M, Park S, Mirocha J, et al. The effect of an nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial[J]. Ann. Inern. Med., 2006, 145:557-563 . 被引量:1
  • 5Lembo A, Zakko S F, Ferreira N L, et al. Rifaximin for the treatment of diarrhea-associated irritable bowel syn- drome: short term treatment leading to long term sustained response[l]. Gastroenterology, 2008, 134(4): A545. 被引量:1
  • 6Kimberly L, Laura H, Johnson H, et al. A combination of rifaximin and neomycin is most effective in treating in'ita- ble bowel syndrome patients with methane on lactnlose breath test[J]. Clin. Gastroenterol., 2010, 44(8): 547-550. 被引量:1
  • 7徐大海,张楠,高金莹,吴扬.肝性脑病治疗进展[J].临床肝胆病杂志,2011,27(2):218-221. 被引量:6
  • 8Fritz E, Hammer H F, Lipp R W, et al. Effects of laetu- lose and polyethylene glycol on colonic transit[J]. Aliment. Pharmaeol. Ther., 2005, 21 (3): 259-268. 被引量:1
  • 9Williams R, James O F, Wames T W, et al. Evaluation of the efficacy and sdety of rifaximin in the treatment of hep- atic eneephalopathy: a double-blind randomized, dose- finding muhicentre study[J]. Eur. J. Gastroenterol. & Hep- atol., 2000, 12(2): 203-208. 被引量:1
  • 10Miglio F, Valpiani D, Rossellini S R, et al. Rifaximin, a non-absorbable rifamycin, for the treatment of hepatic encephalopathy. A double-blind, randomized trial[J]. Curr. Med. Res. Opin., 1997, 13(10): 593-601. 被引量:1

二级参考文献5

共引文献5

同被引文献7

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部